GvHD patients
GvHD mice
Maintenance of GvHD
GvHD maintenance
GvHD initiation
pathogenesis of GvHD
neutrophils
dendritic cells
T cells
loss of epithelial cells
enterocytes
host disease
continuous immune cell activation
high mortality of patients
human studies GvHDCure
epithelial apoptosis
multiple Cre-lox mice
multiple levels
transgenic neutrophil cell lines
miR array
allogeneic hematopoietic cell transplantation
ER stress
molecular programs
combination of murine
sensing of DAMPs
enterocyte death
intestinal tract
immune system
Acute graft
endoplasmic reticulum stress
human tissue bank
overall goal of GvHDCure
verification of regulatory molecular networks
intestinal organoid culture systems
efficient genetic screening
novel imaging methods
micro RNA
selective gene defects
allo-HCT
infiltration
kinase inhibitors
effector function
XBP
inflammation
kinases
leading cause
injury
phospho-proteomics data set
individualized therapeutic strategies
bacterial translocation
miRs
connection
fingerprint
earliest events
intestines
blood cancer
mRNA
reporter mouse
molecules
key event
role
pathophysiological mechanisms
dynamics
addition